2,4,DI (hetero-) arylamino (-oxy)-5-substituted pyrimidines...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S275000, C544S323000, C544S324000, C544S325000, C544S321000, C544S326000, C544S327000, C544S328000

Reexamination Certificate

active

07067522

ABSTRACT:
Pyrimidine derivatives of formula (I) wherein Q1, Q2, G and R1are as defined within; and pharmaceutically acceptable salts and in vivo hydrolysable esters thereof are described. Processes for their manufacture, pharmaceutical compositions and their use as cyclin-dependent serine/threonine kinase (CDK) and focal adhesion kinase (FAK) inhibitors are also described.

REFERENCES:
patent: 4983608 (1991-01-01), Effland et al.
patent: 5516775 (1996-05-01), Zimmermann et al.
patent: 5521184 (1996-05-01), Zimmermann
patent: 5610303 (1997-03-01), Kimura et al.
patent: 5739143 (1998-04-01), Adams et al.
patent: 5859041 (1999-01-01), Liverton et al.
patent: 6593326 (2003-07-01), Bradbury et al.
patent: 6632820 (2003-10-01), Breault et al.
patent: 6649608 (2003-11-01), Pease et al.
patent: 6670368 (2003-12-01), Breault
patent: 6710052 (2004-03-01), Pease et al.
patent: 6716831 (2004-04-01), Breault et al.
patent: 6838464 (2005-01-01), Pease et al.
patent: 6844341 (2005-01-01), Thomas
patent: 6855719 (2005-02-01), Thomas et al.
patent: 6906065 (2005-06-01), Thomas
patent: 6908920 (2005-06-01), Thomas et al.
patent: 2231765 (1998-09-01), None
patent: 0 363 002 (1990-04-01), None
patent: 0 379 806 (1990-08-01), None
patent: 0 564 409 (1993-10-01), None
patent: 0 945 443 (1999-09-01), None
patent: 91/18887 (1991-12-01), None
patent: 92/20642 (1992-11-01), None
patent: 95/09847 (1995-04-01), None
patent: 95/09851 (1995-04-01), None
patent: 95/09852 (1995-04-01), None
patent: 95/09853 (1995-04-01), None
patent: 95/15952 (1995-06-01), None
patent: 96/05177 (1996-02-01), None
patent: 96/28427 (1996-09-01), None
patent: 96/40143 (1996-12-01), None
patent: 97/19065 (1997-05-01), None
patent: 97/35856 (1997-10-01), None
patent: 97/40017 (1997-10-01), None
patent: 97/44326 (1997-11-01), None
patent: 97/47618 (1997-12-01), None
patent: 98/11095 (1998-03-01), None
patent: 98/16230 (1998-04-01), None
patent: 98/18782 (1998-05-01), None
patent: 98/25619 (1998-06-01), None
patent: 98/33798 (1998-08-01), None
patent: 98/41512 (1998-09-01), None
patent: 98/54093 (1998-12-01), None
patent: 98/56788 (1998-12-01), None
patent: 98/01136 (1999-01-01), None
patent: 99/32121 (1999-01-01), None
patent: 98/18096 (1999-04-01), None
patent: 99/18942 (1999-04-01), None
patent: 99/31073 (1999-06-01), None
patent: 99/41253 (1999-08-01), None
patent: 99/50250 (1999-10-01), None
patent: 00/12485 (2000-03-01), None
patent: 00/12486 (2000-03-01), None
patent: 00/17202 (2000-03-01), None
patent: 00/17203 (2000-03-01), None
patent: 00/21926 (2000-04-01), None
patent: 00/25780 (2000-05-01), None
patent: 00/26209 (2000-05-01), None
patent: 00/39101 (2000-07-01), None
patent: 00/44750 (2000-08-01), None
patent: 00/49018 (2000-08-01), None
patent: 00/53595 (2000-09-01), None
patent: 00/55161 (2000-09-01), None
patent: 00/59892 (2000-10-01), None
patent: 00/78731 (2000-12-01), None
patent: 01/14375 (2001-03-01), None
patent: 01/29009 (2001-04-01), None
patent: 01/37835 (2001-05-01), None
patent: 01/47897 (2001-07-01), None
patent: 01/47921 (2001-07-01), None
patent: 01/60816 (2001-08-01), None
patent: 01/64653 (2001-09-01), None
patent: 01/64654 (2001-09-01), None
patent: 01/64655 (2001-09-01), None
patent: 01/72717 (2001-10-01), None
patent: 02/04429 (2002-01-01), None
patent: 02/20512 (2002-03-01), None
patent: 02/066481 (2002-08-01), None
patent: 02/096887 (2002-12-01), None
patent: 03/076433 (2003-09-01), None
patent: 03/076434 (2003-09-01), None
patent: 03/076435 (2003-09-01), None
patent: 03/076436 (2003-09-01), None
Zimmerman et al., Phenylamino-Pyrimidine (PAP) Derivatives: A New Class of Potent and Selective Inhibitors of Protein Kinase C (PKC), Arch. Pharm. Pharm. Med. Chem., vol. 329, 1996, pp. 371-376.
Simone (Bennett et al., Editor), Oncology, Introduction, Cecil Textbook of Medicine, 20th Ed., vol. 1, 1996, pp. 1004-1010.
Kornberg, “Focal adhesion kinase and its potential involvement in tumor invasion and metastasis”, PubMed. Abstract, 9790298, also cited as Head Neck 20(8): 1998, pp. 745-752.
Boschelli et al., Synthesis and Tyrosine Kinase Inhibitory Activity of a Series of 2-Amino-8-H-pyrido[2,3-d]pyrimidines: Identifidation of Potent, Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitors, J. Med. Chem., vol. 41, 1998, pp. 4365-4377.
Deady et al., “Reactions of some Quinazoline Compounds with Ethoxymethylenemalonic Acid Derivatives”, J. Heterocyclic Chem., vol. 26, 1989, pp. 161-168.
Donnellan et al., “Cyclin E in human cancers”, FASEB Journal, 13, 1999, pp. 773-780.
El-Kerdawy et al.; “2,4-Bis (Substituted)-5-Nitropyrimidines of Expected Diuretic Action”; Egypt J. Chem. vol. 29, No. 2, 1986, pp. 247-251.
Fiziol Akt Veshchestva, 1975, vol. 7, pp. 68-72.
Ghosh et al.; “2,4-Bis(arylamino)-5-methylpyrimidines as Antimicrobial Agents”; J. Med. Chem., 1967, vol. 10, No. 5, pp. 974-975.
Ghosh, “2,4-Bis(Arylamino)-6-Methyl Pyrimidines as Antimicrobial Agents”, J. Indian Chem. Soc., vol. 58, No. 5, 1981, pp. 512-513.
Ghosh, “2,4-Bis(arylamino)-6-methylpyrimidines as an antimicrobial agents”, Chemical Abstract No. 97712f, vol. 95, 1981, pp. 648.
Schmidt et al.; “A Convenient Synthesis of 2-substituted 4-Amino-5-pyrimidinecarbonitriles”; J. Heterocycle Chem., 1997, vol. 24, No. 5, pp. 1305-1307.
U.S. Appl. No. 09/763,705, filed Feb. 26, 2001, Breault et al.
U.S. Appl. No. 10/771,118, filed Feb. 4, 2004, Breault et al.
U.S. Appl. No. 10/220,139, filed Aug. 28, 2002, Pease et al.
U.S. Appl. No. 10/753,959, filed Jan. 9, 2004, Pease et al.
U.S. Appl. No. 10/363,655, filed Mar. 4, 2003, Breault et al.
U.S. Appl. No. 10/479,041, filed Nov. 26, 2003, Newcombe.
U.S. Appl. No. 10/507,162, filed Sep. 9, 2004, Newcombe et al.
U.S. Appl. No. 10/507,081, filed Sep. 9, 2004, Newcombe et al.
U.S. Appl. No. 10/507,169, filed Sep. 9, 2004, Newcombe et al.
U.S. Appl. No. 10/507,163, filed Sep. 9, 2004, Newcombe et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2,4,DI (hetero-) arylamino (-oxy)-5-substituted pyrimidines... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2,4,DI (hetero-) arylamino (-oxy)-5-substituted pyrimidines..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,4,DI (hetero-) arylamino (-oxy)-5-substituted pyrimidines... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3686184

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.